← All trials
NCT05017467
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2011
- Primary completion
- Jan 5, 2020
- Completion date
- Apr 1, 2020
- First posted
- Aug 23, 2021
- Last posted
- Aug 23, 2021
- Enrollment
- 280
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Konya Numune HospitalLead sponsor
- Istanbul Medipol UniversityOverall official - principal investigator
- Konya Numune HospitalSponsor investigator
- Konya Numune HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.